Biosafety Guidelines for Novel Coronavirus (SARS-CoV-2) – Coronavirus disease (COVID-19)
The following biosafety guidelines are available to assist laboratories in the safe handling of samples containing the novel coronavirus (2019-nCoV).
World Health Organization
Advice on the use of masks in the context of COVID-19
Assessment tool for laboratories implementing COVID-19 virus testing – Access the tool
Guide to Local Production – WHO recommended Hand-rub formulations
Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)
Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance (19 March 2020)
Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) update (18 March 2020)
Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases, Interim guidance
Naming the coronavirus disease (COVID-2019) and the virus that causes it (SARS-CoV-2)
Operational considerations for managing COVID-19 cases or outbreak in aviation
Personal protective equipment (PPE) – How to put on and take off
Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19)
Severe Acute Respiratory Infections Treatment Centre
Africa
Public Health Agency of Canada
Novel Coronavirus from Wuhan, China (2019-nCoV) Biosafety Advisory
European Union
Infection prevention and control for COVID-19 in healthcare settings, March 2020
Interpol
COVID-19 Pandemic Guidelines for Law enforcement
Singapore
United Kingdom
Handling and processing of laboratory specimens, Guidance – Wuhan novel coronavirus
Packaging requirements for COVID-19 samples
Suspected COVID-19 cases – samples and packaging
US Centers for Disease Control and Prevention
Best Practices for Environmental Cleaning in Healthcare Facilities in Resource Limited Settings
Other Guidance and Resources